While psychedelics reform is clearly gaining momentum, not only in the U.S. but notably in places like Australia and less so Canada. The fact is, all compounds remain currently Schedule I drugs (or equivalents) and thus federally illegal in many countries including the U.S.
The regulatory advances on these substances have been joined by an also-clear change in public perception, which is not to say that psychedelics were unknown to people before. Now, they have effectively entered the mainstream and are being considered by a greater majority looking at their therapeutic potential as mental health treatments.
This is the case especially for psilocybin mushrooms, considering the numerous and acclaimed tales on microdosing’s …